A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial NCT06752356 · RECRUITING
Trial details
- NCT number
- NCT06752356
- Sponsor
- Kedrion S.p.A.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-12-20
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.